PT  - JOURNAL ARTICLE
AU  - Natalie Y. Barnes
AU  - Ling Li
AU  - Kazuaki Yoshikawa
AU  - Lawrence M. Schwartz
AU  - Ronald W. Oppenheim
AU  - Carolanne E. Milligan
TI  - Increased Production of Amyloid Precursor Protein Provides a Substrate for Caspase-3 in Dying Motoneurons
AID  - 10.1523/JNEUROSCI.18-15-05869.1998
DP  - 1998 Aug 01
TA  - The Journal of Neuroscience
PG  - 5869--5880
VI  - 18
IP  - 15
4099  - http://www.jneurosci.org/content/18/15/5869.short
4100  - http://www.jneurosci.org/content/18/15/5869.full
SO  - J. Neurosci.1998 Aug 01; 18
AB  - Biochemical and molecular mechanisms of neuronal cell death are currently an area of intense research. It is well documented that the lumbar spinal motoneurons of the chick embryo undergo a period of naturally occurring programmed cell death (PCD) requiring new gene expression and activation of caspases. To identify genes that exhibit changed expression levels in dying motoneurons, we used a PCR-based subtractive hybridization protocol to identify messages uniquely expressed in motoneurons deprived of trophic support as compared with their healthy counterparts. We report that one upregulated message in developing motoneurons undergoing cell death is the mRNA for amyloid precursor protein (APP). Increased levels of APP and β-amyloid protein are also detected within dying motoneurons. The predicted peptide sequence of APP indicates two potential cleavage sites for caspase-3 (CPP-32), a caspase activated in dying motoneurons. When peptide inhibitors of caspase-3 are administered to motoneurons destined to undergo PCD, decreased levels of APP protein and greatly reduced β-amyloid production are observed. Furthermore, we show that APP is cleaved by caspase-3. Our results suggest that differential gene expression results in increased levels of APP, providing a potential substrate for one of the cell death-activated caspases that may ultimately cause the demise of the cell. These results, combined with information on the toxic role of APP and its proteolytic by-product β-amyloid, in the neurodegenerative disease Alzheimer’s, suggest that events of developmental PCD may be reactivated in early stages of pathological neurodegeneration.